AbbVie Inc. Income Taxes Paid
AbbVie Inc. (ABBV) reported Income Taxes Paid of $4.06 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2025-02-14
- AbbVie Inc. income taxes paid for fiscal 2024 was $4.06B, a 13.57% decline from fiscal 2023.
- AbbVie Inc. income taxes paid for fiscal 2023 was $4.70B, a 57.36% increase from fiscal 2022.
- AbbVie Inc. income taxes paid for fiscal 2022 was $2.99B, a 18.09% decline from fiscal 2021.
- AbbVie Inc. income taxes paid for fiscal 2021 was $3.65B, a 117.92% increase from fiscal 2020.
| Period end | Income Taxes Paid 12 month |
|---|---|
| 2024-12-31 | $4.06B 10-K · filed 2025-02-14 |
| 2023-12-31 | $4.70B 10-K · filed 2025-02-14 |
| 2022-12-31 | $2.99B 10-K · filed 2025-02-14 |
| 2021-12-31 | $3.65B 10-K · filed 2024-02-20 |
| 2020-12-31 | $1.67B 10-K · filed 2023-02-17 |
| 2019-12-31 | $1.45B 10-K · filed 2022-02-18 |
| 2017-12-31 | $1.70B 10-K · filed 2020-02-21 |
| 2016-12-31 | $3.56B 10-K · filed 2019-02-27 |
| 2015-12-31 | $1.11B 10-K · filed 2018-02-16 |
| 2014-12-31 | $498.00M 10-K · filed 2017-02-17 |
| 2013-12-31 | $1.30B 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |